Long-term Outcomes of Patients After Coronary Bifurcation Stenting
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00325884|
Recruitment Status : Completed
First Posted : May 15, 2006
Last Update Posted : August 29, 2011
|Condition or disease||Phase|
|Coronary Artery Disease Death Myocardial Infarction||Phase 4|
Coronary artery disease affecting the branch points of coronary arteries (bifurcation lesions) has a higher rate of restenosis after angioplasty than disease in regions not involving branch points. Post-procedural angiographic outcomes and in-hospital outcomes have been documented for a variety of techniques, but none have examined the long-term clinical outcomes.
Long-term clinical outcomes are important from the patients point of view and also determine the use of resources. Knowledge of the long-term outcomes from the various techniques used to treat bifurcation lesions would be important in determining guidelines for the treatment of bifurcation lesions. If simple techniques offer similar or better outcomes than more complex strategies, then this would justify simpler techniques such as main vessel stenting that would use less resources, expose the patient to less radiation, and contrast related to prolonged angioplasty procedures.
Comparisons: We will compare the long-term outcomes of simple versus complex stent techniques, and determine other risk factors for long-term outcome
|Study Type :||Observational|
|Actual Enrollment :||160 participants|
|Official Title:||Long-term Outcomes of Patients After Coronary Bifurcation Stenting|
|Study Start Date :||August 2001|
|Primary Completion Date :||August 2005|
|Study Completion Date :||August 2005|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00325884
|United States, Massachusetts|
|VA Boston Healthcare System|
|West Roxbury, Massachusetts, United States, 02132|
|Principal Investigator:||Scott Kinlay, MBBS, PhD||VA Boston Healthcare System|